Page 36 - Breakthrough Device News Today

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Desig

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.

BURLINGAME, Calif.--(BUSINESS WIRE)--Oct 29, 2021--

Spinal surgery is not for the faint of heart at the best of times, but Intelligent Implants raised €7.5 million ($8.7 million) to make spinal surgery less of a pain in the backside. The company’s smart implants’ first application is in spinal fusion surgery — where two or more vertebrae are permanently connected to improve […]

Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 21, 2021) - Neovasc Inc.

LONDON and SALT LAKE CITY, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro...

Intersect Healthcare Inc., Towson, Maryland, has issued a public comment on the Centers for Medicare and Medicaid Services proposed rule entitled "Medicare Program: Medicare Coverage of Innovative Technology and Definition of Reasonable and Necessary". The comment was co-signed by Brian McGraw, president; Raymond Kendall Smith Jr., chief physician advisor;...

Lucid Diagnostics Inc., a company that produces esophageal cancer tests based on Case Western Reserve University and University Hospitals research, has complete

Company’s esophageal cancer prevention tests developed jointly by medical school faculty at Case Western Reserve University and University Hospitals

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today...